IDEAS home Printed from https://ideas.repec.org/a/gam/jijerp/v20y2023i7p5296-d1109856.html
   My bibliography  Save this article

Quality-Adjusted Life Years in Erythropoietic Protoporphyria and Other Rare Diseases: A Patient-Initiated EQ-5D Feasibility Study

Author

Listed:
  • Jasmin Barman-Aksözen

    (International Porphyria Patient Network (IPPN), 8032 Zurich, Switzerland
    Institute of Laboratory Medicine, Municipal Hospital Zurich Triemli, 8063 Zurich, Switzerland
    Swiss Reference Centre for Porphyrias, Municipal Hospital Zurich Triemli, 8063 Zurich, Switzerland
    These authors contributed equally to this work.)

  • Anna-Elisabeth Minder

    (Swiss Reference Centre for Porphyrias, Municipal Hospital Zurich Triemli, 8063 Zurich, Switzerland
    Division for Endocrinology, Diabetology and Porphyria, Municipal Hospital Zurich Triemli, 8063 Zurich, Switzerland
    These authors contributed equally to this work.)

  • Francesca Granata

    (International Porphyria Patient Network (IPPN), 8032 Zurich, Switzerland
    Fondazione IRCCS Ca’ Granda Ospedale Maggiore Policlinico, S.C Medicine and Metabolic Disorders, 20122 Milano, Italy)

  • Mårten Pettersson

    (International Porphyria Patient Network (IPPN), 8032 Zurich, Switzerland)

  • Cornelia Dechant

    (International Porphyria Patient Network (IPPN), 8032 Zurich, Switzerland)

  • Mehmet Hakan Aksözen

    (International Porphyria Patient Network (IPPN), 8032 Zurich, Switzerland)

  • Rocco Falchetto

    (International Porphyria Patient Network (IPPN), 8032 Zurich, Switzerland)

Abstract

Erythropoietic protoporphyria (EPP) is an ultra-rare inborn error of metabolism characterised by painful phototoxic burn injuries after short exposure times to visible light. Patients with EPP are highly adapted to their condition which makes the quantification of their health-related quality of life (QoL) challenging. In the presented patient-initiated feasibility study, we describe a new approach to assess treatment benefits in EPP by measuring QoL with the generic EQ-5D instrument in five patients under long-term (≥two years) treatment with afamelanotide, the first approved therapy for EPP. For the study, we selected patients with EPP who in addition were affected by an involuntary treatment interruption (caused by a temporary reimbursement suspension) because we hypothesized that individuals who had previously unlearned their adaptation are better able to assess their life without treatment than treatment-naïve patients. QoL under treatment was comparable to the age-matched population norm, and retrospective results for a treatment interruption and phototoxic reaction time point were comparable to the QoL of patients with chronic neuropathic pain and acute burn injuries, respectively. The results were accepted by the National Institute for Health and Care Excellence in England for their evaluation of the cost-effectiveness of afamelanotide, i.e., the calculation of quality-adjusted life years.

Suggested Citation

  • Jasmin Barman-Aksözen & Anna-Elisabeth Minder & Francesca Granata & Mårten Pettersson & Cornelia Dechant & Mehmet Hakan Aksözen & Rocco Falchetto, 2023. "Quality-Adjusted Life Years in Erythropoietic Protoporphyria and Other Rare Diseases: A Patient-Initiated EQ-5D Feasibility Study," IJERPH, MDPI, vol. 20(7), pages 1-15, March.
    • Handle: RePEc:gam:jijerp:v:20:y:2023:i:7:p:5296-:d:1109856
    as

    Download full text from publisher

    File URL: https://www.mdpi.com/1660-4601/20/7/5296/pdf
    Download Restriction: no
    File URL: https://www.mdpi.com/1660-4601/20/7/5296/
    Download Restriction: no
    ---><---

    References listed on IDEAS

    as
    1. Nancy J. Devlin & Richard Brooks, 2017. "EQ-5D and the EuroQol Group: Past, Present and Future," Applied Health Economics and Health Policy, Springer, vol. 15(2), pages 127-137, April.
    2. Efthymiadou, Olina & Mossman, Jean & Kanavos, Panos, 2019. "Health related quality of life aspects not captured by EQ-5D-5L: Results from an international survey of patients," Health Policy, Elsevier, vol. 123(2), pages 159-165.
    3. Patricia Cubí‐Mollá & Mireia Jofre‐Bonet & Victoria Serra‐Sastre, 2017. "Adaptation to health states: Sick yet better off?," Health Economics, John Wiley & Sons, Ltd., vol. 26(12), pages 1826-1843, December.
    4. Werner Brouwer & Pieter Baal & Job Exel & Matthijs Versteegh, 2019. "When is it too expensive? Cost-effectiveness thresholds and health care decision-making," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(2), pages 175-180, March.
    5. S. Ghislandi & G. Apolone & L. Garattini & I. Ghislandi, 2002. "Is EQ-5D a valid measure of HRQoL in patients with movement disorders?," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 3(2), pages 125-130, June.
    6. Rocco Falchetto, 2020. "The Patient Perspective: A Matter of Minutes," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 13(1), pages 1-6, February.
    Full references (including those not matched with items on IDEAS)

    Citations

    Citations are extracted by the CitEc Project, subscribe to its RSS feed for this item.
    as


    Cited by:

    1. Jasmin Barman-Aksözen & Nicole Hentschel & Mårten Pettersson & Eva Schupp & Francesca Granata & Cornelia Dechant & Mehmet Hakan Aksözen & Rocco Falchetto, 2024. "Fair Funding Decisions: Consistency of the Time Horizons Used in the Calculation of Quality-Adjusted Life Years for Therapies for Very Rare Diseases by the National Institute for Health and Care Excel," IJERPH, MDPI, vol. 21(5), pages 1-14, May.

    Most related items

    These are the items that most often cite the same works as this one and are cited by the same works as this one.
    1. Stefan A. Lipman & Liying Zhang & Koonal K. Shah & Arthur E. Attema, 2023. "Time and lexicographic preferences in the valuation of EQ-5D-Y with time trade-off methodology," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 24(2), pages 293-305, March.
    2. Beth Woods & James Lomas & Mark Sculpher & Helen Weatherly & Karl Claxton, 2024. "Achieving dynamic efficiency in pharmaceutical innovation: Identifying the optimal share of value and payments required," Health Economics, John Wiley & Sons, Ltd., vol. 33(4), pages 804-819, April.
    3. de Hond, Anne & Bakx, Pieter & Versteegh, Matthijs, 2019. "Can time heal all wounds? An empirical assessment of adaptation to functional limitations in an older population," Social Science & Medicine, Elsevier, vol. 222(C), pages 180-187.
    4. Hannah Christensen & Hareth Al-Janabi & Pierre Levy & Maarten J. Postma & David E. Bloom & Paolo Landa & Oliver Damm & David M. Salisbury & Javier Diez-Domingo & Adrian K. Towse & Paula K. Lorgelly & , 2020. "Economic evaluation of meningococcal vaccines: considerations for the future," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(2), pages 297-309, March.
    5. Longobardo, Luz María Peña & Rodríguez-Sánchez, Beatriz & Oliva, Juan, 2023. "Does becoming an informal caregiver make your health worse? A longitudinal analysis across Europe," Economics & Human Biology, Elsevier, vol. 50(C).
    6. Richard De Abreu Lourenço & Nancy Devlin & Kirsten Howard & Jason J. Ong & Julie Ratcliffe & Jo Watson & Esther Willing & Elisabeth Huynh, 2021. "Giving a Voice to Marginalised Groups for Health Care Decision Making," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(1), pages 5-10, January.
    7. Peiyi Lu & Ying Liang, 2016. "Health-Related Quality of Life of Young Chinese Civil Servants Working in Local Government: Comparison of SF-12 and EQ5D," Applied Research in Quality of Life, Springer;International Society for Quality-of-Life Studies, vol. 11(4), pages 1445-1464, December.
    8. Stöckel, Jannis & van Exel, Job & Brouwer, Werner B.F., 2023. "Adaptation in life satisfaction and self-assessed health to disability - Evidence from the UK," Social Science & Medicine, Elsevier, vol. 328(C).
    9. Fengrong Ou & Kai Li & Qian Gao & Dan Liu & Jinghai Li & Liwen Hu & Xian Wu & E Kale Edmiston & Yang Liu, 2012. "An Urban Neo-Poverty Population-Based Quality of Life and Related Social Characteristics Investigation from Northeast China," PLOS ONE, Public Library of Science, vol. 7(6), pages 1-7, June.
    10. Garattini, Livio & van de Vooren, Katelijne & Zaniboni, Alberto, 2013. "Ethics for end-of-life treatments: Metastatic colorectal cancer is one example," Health Policy, Elsevier, vol. 109(1), pages 97-103.
    11. Cassandra Mah & Vanessa K. Noonan & Stirling Bryan & David G. T. Whitehurst, 2021. "Empirical Validity of a Generic, Preference-Based Capability Wellbeing Instrument (ICECAP-A) in the Context of Spinal Cord Injury," The Patient: Patient-Centered Outcomes Research, Springer;International Academy of Health Preference Research, vol. 14(2), pages 223-240, March.
    12. Sebastian Himmler & Job Exel & Werner Brouwer, 2020. "Estimating the monetary value of health and capability well-being applying the well-being valuation approach," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 21(8), pages 1235-1244, November.
    13. McDaid, David & Park, A-La, 2023. "Making an economic argument for investment in global mental health: the case of conflict-affected refugees and displaced people," LSE Research Online Documents on Economics 118149, London School of Economics and Political Science, LSE Library.
    14. Charles F. Manski, 2023. "Using Limited Trial Evidence to Credibly Choose Treatment Dosage when Efficacy and Adverse Effects Weakly Increase with Dose," NBER Working Papers 31305, National Bureau of Economic Research, Inc.
    15. Peña-Longobardo, L.M. & Rodríguez-Sánchez, B. & Oliva-Moreno, J., 2021. "The impact of widowhood on wellbeing, health, and care use: A longitudinal analysis across Europe," Economics & Human Biology, Elsevier, vol. 43(C).
    16. Hernández-Alava, Mónica & Pudney, Stephen, 2017. "Econometric modelling of multiple self-reports of health states: The switch from EQ-5D-3L to EQ-5D-5L in evaluating drug therapies for rheumatoid arthritis," Journal of Health Economics, Elsevier, vol. 55(C), pages 139-152.
    17. Márta Péntek & Ottó Hajdu & Fanni Rencz & Zsuzsanna Beretzky & Valentin Brodszky & Petra Baji & Zsombor Zrubka & Klára Major & László Gulácsi, 2019. "Subjective expectations regarding ageing: a cross-sectional online population survey in Hungary," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 20(1), pages 17-30, June.
    18. Vivian Reckers-Droog & Joost Enzing & Werner Brouwer, 2024. "The role of budget impact and its relationship with cost-effectiveness in reimbursement decisions on health technologies in the Netherlands," The European Journal of Health Economics, Springer;Deutsche Gesellschaft für Gesundheitsökonomie (DGGÖ), vol. 25(8), pages 1449-1459, November.
    19. Héctor Pifarré i Arolas & Christian Dudel, 2019. "An Ordinal Measure of Population Health," Social Indicators Research: An International and Interdisciplinary Journal for Quality-of-Life Measurement, Springer, vol. 143(3), pages 1219-1243, June.
    20. Oksuzyan, Anna & Dańko, Maciej J. & Caputo, Jennifer & Jasilionis, Domantas & Shkolnikov, Vladimir M., 2019. "Is the story about sensitive women and stoical men true? Gender differences in health after adjustment for reporting behavior," Social Science & Medicine, Elsevier, vol. 228(C), pages 41-50.

    Corrections

    All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:gam:jijerp:v:20:y:2023:i:7:p:5296-:d:1109856. See general information about how to correct material in RePEc.

    If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.

    If CitEc recognized a bibliographic reference but did not link an item in RePEc to it, you can help with this form .

    If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.

    For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: MDPI Indexing Manager (email available below). General contact details of provider: https://www.mdpi.com .

    Please note that corrections may take a couple of weeks to filter through the various RePEc services.

    IDEAS is a RePEc service. RePEc uses bibliographic data supplied by the respective publishers.